Next update of the European breast cancer guidelines

On 14 December 2022, the ECIBC’s Guideline Development Group met virtually to prepare for the fourth update of the European guidelines on breast cancer screening and diagnosis, which will take place during 2023 and 2024.

During this round of update, the following healthcare questions will be addressed in the guidelines, resulting in the formulation of recommendations:

• Should screening using digital breast tomosynthesis (DBT) vs. digital mammography be used in organised screening programmes for early detection of breast cancer in asymptomatic women?
• Should DBT vs. digital mammography be used in organised screening programmes for early detection of breast cancer in women with high mammographic breast density detected in previous screening exams?
• Should DBT vs. MRI be used in organised screening programmes for early detection of breast cancer in women with high mammographic breast density detected in previous screening exams?
• Should MRI in addition to DBT vs. DBT alone be used in organised screening programmes for early detection of breast cancer in women with high mammographic breast density detected in previous screening exams?
• Should tailored screening with additional DBT vs. no additional DBT be used in organised screening programmes for early detection of breast cancer in women with high mammographic breast density detected for the first time with digital mammography in screening?
• Should tailored screening with additional MRI vs. no additional MRI be used in organised screening programmes for early detection of breast cancer in women with high mammographic breast density detected for the first time with digital mammography in screening?
• Should single reading supported by artificial intelligence vs. double reading without artificial intelligence support be used to read mammograms using digital mammography (2DFFDM) or digital breast tomosynthesis for early detection of breast cancer in mammography screening programmes?
• Should double reading with support by artificial intelligence vs. double reading without support by artificial intelligence be used to read mammograms using digital mammography (2DFFDM) or digital breast tomosynthesis for early detection of breast cancer in mammography screening programmes?